SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-22-021838
Filing Date
2022-08-10
Accepted
2022-08-10 09:20:33
Documents
69
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 812977
2 ex31-1.htm EX-31.1 20136
3 ex31-2.htm EX-31.2 18874
4 ex32-1.htm EX-32.1 8032
  Complete submission text file 0001493152-22-021838.txt   4140241

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE pulm-20220630.xsd EX-101.SCH 39241
6 XBRL CALCULATION FILE pulm-20220630_cal.xml EX-101.CAL 52288
7 XBRL DEFINITION FILE pulm-20220630_def.xml EX-101.DEF 131679
8 XBRL LABEL FILE pulm-20220630_lab.xml EX-101.LAB 302473
9 XBRL PRESENTATION FILE pulm-20220630_pre.xml EX-101.PRE 227266
63 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 564924
Mailing Address 99 HAYDEN AVENUE SUITE 390 LEXINGTON MA 02421
Business Address 99 HAYDEN AVENUE SUITE 390 LEXINGTON MA 02421 (781) 357-2333
Pulmatrix, Inc. (Filer) CIK: 0001574235 (see all company filings)

IRS No.: 461821392 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36199 | Film No.: 221150604
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences